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Bacteria belonging to the genus Mycobacterium are predominantly responsible for
pulmonary diseases; most notably Mycobacterium tuberculosis causes granulomatous
pulmonary infections. Here we describe a novel slow growing mycobacterial species
isolated from respiratory samples from five patients, four with underlying pulmonary
disease. The isolates were characterized by biochemical and molecular techniques,
including whole genome sequencing. Biochemical characteristics generally match those
of M. marinum and M. ulcerans; however, the most striking difference of the new
species is its ability to grow at 37◦C. The new species was found to grow in human
macrophages, but not amoebae, suggesting a pathogenic rather than an environmental
lifestyle. Phylogenetic analysis reveals a deep-rooting relationship to M. marinum and
M. ulcerans. A complete genome sequence was obtained through combining short and
long-read sequencing, providing a genome of 5.6 Mb. The genome appears to be highly
intact, syntenic with that of M. marinum, with very few insertion sequences. A vast array
of virulence factors includes 283 PE/PPE surface-associated proteins, making up 10%
of the coding capacity, and 22 non-ribosomal peptide synthase clusters. A comparison
of six clinical isolates from the five patients shows that they differ by up to two single
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nucleotide polymorphisms, suggesting a common source of infection. Our findings are
in accordance with the recognition of a new taxonomic entity. We propose the name
M. basiliense, as all isolates were found in patients from the Basel area of Switzerland.
Keywords: nontuberculous mycobacteria, novel species, Mycobacterium basiliense, virulence, pathogen
INTRODUCTION
The incidence of nontuberculous mycobacteria (NTM) infection
has increased over the past decades, with pulmonary disease
being the most common clinical manifestation, affecting mainly
immunocompromised patients (Donohue and Wymer, 2016;
Stout et al., 2016; Sood and Parrish, 2017). This is partly due
increased awareness and detection, which has also led to the
identification and description of more species within the NTM,
with over 180 now listed (Sood and Parrish, 2017; Oren and
Garrity, 2018). Many have been phylogenetically characterized
using genome sequences (Fedrizzi et al., 2017), with additional
genus subdivisions now proposed (Gupta et al., 2018). With the
exception of Mycobacterium tuberculosis that co-evolved with
primates, most mycobacteria are saprophytic bacteria that are
evolutionarily adapted to soil or aquatic environments, acting as
facultative pathogens in humans.
Mycobacterium ulcerans and M. marinum are well
characterized, slow growing NTM. Strains of M. ulcerans
are the causative agents of chronic non-healing skin and soft
tissue infections, primarily in tropical and sub-tropical countries
in Africa and Australia (Guarner, 2018). Clinical isolates of
M. ulcerans produce variants of a cytotoxic pro-apoptotic toxin
(mycolactone), which is considered as the major virulence factor
contributing to the non-healing skin lesions (Yip et al., 2007;
Tobias et al., 2009). Skin infections caused by M. marinum have
been described in fish-tank and frog vivarium owners (Johnson
and Stout, 2015). Members of M. marinum and M. ulcerans
infect exterior human body sites, as pathogen growth is restricted
to a range of 28–33◦C (World Health Organization [WHO] et al.,
2001).
Genomic studies on mycobacteria have produced reference
genomes for key strains of M. tuberculosis, M. marinum, and
M. ulcerans (Cole et al., 1998; Stinear et al., 2007, 2008). These
have resulted in the observation that M. marinum represents
a more ancestral genomic state, as a generalist bacterium
able to survive in various environments as well as causing
disease, in comparison to M. tuberculosis, which has undergone
significant genome reduction and reorganization through
insertion sequence (IS) expansion to become a specialized
pathogen. M. ulcerans has undergone a similar process in parallel,
and has also acquired a virulence plasmid carrying genes which
encode the immunosuppressive polyketide toxin mycolactone
(Doig et al., 2012).
Here, we present a novel species of Mycobacterium that is
related to M. marinum and M. ulcerans, and has been associated
with five cases of NTM pulmonary infection. We describe
the clinical and microbiological features of these cases and
provide phenotypic and genomic characterization of the infecting
mycobacterial isolates. We propose the name Mycobacterium
basiliense sp. nov., as all isolates were recovered from patients in
the Basel area of Switzerland.
MATERIALS AND METHODS
Patient Consent and Bacterial Isolates
Written informed consent was provided by all patients.
Mycobacterial cultures were grown from respiratory samples
of all five patients in mycobacterial growth indicator tubes
(MGIT 960, Becton Dickinson, Heidelberg, Germany). Positive
cultures were further analyzed using a Ziehl-Neelsen and
auramine-rhodamine staining. After detection of acid-fast
rods in microscopy, we used the GenoType Mycobacterium
CM (Hain Lifescience, Nehren, Germany) for further species
determination. Cell morphology was analyzed after auramine-
rhodamine staining. All isolation work was carried out in an ISO
17025 accredited clinical microbiology laboratory using internal
controls for growth (ATCC R© 27294) and microscopy (Axonlab,
Luzern, Switzerland) as standard. Laboratory contamination is
highly unlikely, especially as isolates were found sporadically over
four years, and also in one case within samples from the same
patient.
Genomic DNA Extraction and 16S rRNA
Gene Sequencing
Genomic DNA was extracted by Qiagen EZ1 (Qiagen, Hilden,
Germany) using the DNA tissue kit (Qiagen) after inactivation
at 95◦C for 1 h and disruption in a TissueLyser (Qiagen) for
2 min at highest frequency. For species identification a 1026 bp
fragment of the rrs gene encoding the 16S rRNA was generated by
PCR, using the oligonucleotides Mbak-f283 5′-GAG TTT GAT
CCT GGC TCA GGA-3′ and Mbak-r264 5′-TGC ACA CAG
GCC ACA AGG GA-3′ adapted from (Boddinghaus et al., 1990).
Amplicons were sequenced using Mbak14 (5′- GRG RTA CTC
GAG TGG CGA AC-3′), producing reads of up to 750 bp.
Phenotypic properties and
Matrix-Assisted Laser Desorption
Ionization-Time of Flight (MALDI-TOF)
mass spectrometry (MS)
Growth of type strain 901379 (the first isolate, from 2013)
was assessed using 7H10 agar plates + 10% OADC growth
supplement, after incubation for 14 days at either 30◦C or
37◦C. A standard series of biochemical tests and morphological
examination were performed as described in (Pfyffer, 2015).
MALDI-TOF MS profiles were acquired on a Bruker microflex
system and interpreted using the Bruker mycobacterial database
(version 3.0). (Detailed methods are in Supplementary File 1).
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Antimicrobial Susceptibility Testing (AST)
Antimicrobial susceptibility testing (AST) was performed using
MGIT 960/TB eXiST DST (Becton Dickinson) as previously
described for slow growing NTM (Lucke et al., 2012).
Briefly, isolates were examined using a modified automated
macrodilution assay with defined drug concentrations below and
above the epidemiologic cutoff values (ECOFF) of the individual
antimicrobial compounds. Tested compounds and the respective
concentrations were as follows: clarithromycin at 4, 16, 32, and
64 mg/L; ethambutol at 5, 12.5, and 50 mg/L; rifabutin at 0.1,
0.4, and 2 mg/L; rifampicin at 1, 4, and 20 mg/L; clofazimine
at 1 and 2 mg/L; amikacin at 1, 4, and 20 mg/L; moxifloxacin
at 0.5, 2.5, and 10 mg/L; linezolid at 1, 4, and 16 mg/L. Growth
was monitored with the EpiCenter software and the TB eXiST
module (Becton Dickinson). Resistance categories of the isolates
(resistant/intermediate/susceptible) were determined as defined
(Springer et al., 2009).
Mycolic Acid Analysis Using
High-Performance Liquid
Chromatography (HPLC)
Cell-wall mycolic acids were analyzed by HPLC as described
recently (Nogueira et al., 2015; Hashemi Shahraki et al., 2017),
following the recommendations of the Sherlock Mycobacteria
Identification System (SMIS; MIDI). In brief, cells were grown on
Middlebrook 7H10 agar, saponified, extracted, and derivatised.
Mycolic acids were separated with a gradient of methanol and
2-propanol on an Agilent ChemStation 1100/1200 HPLC system.
Peak integration and identification were performed with the
MIDI Sherlock Software version 4.0.
In vitro Cell and Amoebal Growth
Detailed methods are given in Supplementary File 1.
M. basiliense strain 901379 was used to infect both THP-1
human macrophages and Acanthamoeba castellanii ATCC 30010
at a multiplicity of infection (MOI) of 10 and 5, by centrifugation
at 1790 g for 10 min and subsequent incubation for 30 min.
Infected THP-1 cells were grown in RPMI supplemented
with 10% Fetal Calf Serum at 37◦C in a 5% CO2 humidified
atmosphere. A. castellanii were grown at 25◦C in Page’s Amoeba
Saline Solution (PAS) (Jacquier et al., 2013). Samples were taken
at 0, 24, 48, 72, and 96 h, after 2 h’ treatment with 150 µg/ml
gentamycin, using TrypLE Express (Thermo Fisher Scientific,
United States) to detach THP-1 cells.
Amoebal cell suspension or THP-1 cells were diluted in
phosphate buffered saline (PBS) and shaken with 4 mm beads
to lyse the host cells. Colony-forming units (CFU) from serial
dilutions were measured after growth on 7H10 Middlebrook agar
plates at 37◦C, 5% CO2 humidified atmosphere.
For Ziehl-Neelsen staining, 300 µl of cell suspension were
spun onto coverslips at 1000 g for 5 min. After drying, the
coverslips were heat fixated at 95◦C for 10 min before staining.
In parallel, DNA from infected cells was extracted using RTP R©
MYCOBACTERIA KIT (STRATEC, Germany; manufacturer’s
protocol 2 without the N-Acetyl-Cysteine step). Mycobacterial
DNA was quantified in duplicate by qPCR method C (Radomski
et al., 2010) using a StepOne Real-Time PCR System (Applied
Biosystems, Thermo Fisher Scientific, United States).
Genome Sequencing, Assembly,
Annotation and Mapping
All isolates were sequenced following Nextera library creation,
on the Illumina Miseq platform using 300 bp paired end reads,
within the Division of Clinical Microbiology, University Hospital
Basel. DNA extracted from the type strain 901379 was sequenced
on the Pacific Biosciences RSII platform using one SMRT cell, at
the Functional Genomics Centre Zürich (FGCZ), ETH Zürich.
PacBio reads (mean 140-fold coverage) were assembled using
the RS_HGAP_Assembly.3 protocol implemented in SMRT
Portal version 2.3.0. Illumina reads were mapped onto the
resulting contig by using BWA to improve the sequence quality.
Annotation was performed using Prokka 1.8 with further
manual curation in Artemis (Rutherford et al., 2000) and
Artemis Comparison Tool (ACT) (Carver et al., 2005), and the
chromosome split at dnaA representing oriC. The draft genome
was curated for the presence of pseudogenes, defined as putative
coding sequences (CDSs) disrupted by one or more mutations
that would ablate expression (i.e., indel causing frameshift or
substitution causing premature stop codon). Mapping of MiSeq
data was performed within CLC Genomics Workbench 9, giving
mean MiSeq read coverage values of 901379: 52×, 900310: 37×,
903442: 119×, 902333: 61×, and 902167: 47×. This software
was also used to perform variant calling using the parameters:
8× min coverage, 8 min count and 50% min frequency, with
manual checking of all called variants. (The same results were
achieved using 10× min coverage, 10 min count and 70% min
frequency). A single nucleotide polymorphism (SNP) phylogeny
was generated from high quality confirmed SNPs.
Genome Analysis
Average nucleotide identity (ANI) determination was performed
at enve-omics.ce.gatech.edu/ani/ (Goris et al., 2007) and
digital DNA-DNA hybridization (dDDH) using GGDC2.11 and
the DDH cut off of ≤70% (Auch et al., 2010). For the
core-genome phylogeny, translated CDSs were clustered into
orthologous groups using OrthoFinder v2.2.1 (Emms and Kelly,
2015) and single-copy orthologous genes were aligned using
Mafft v7.310 (Katoh and Standley, 2013). The length of the
concatenated alignment of 793 CDSs was 283,167 amino acids.
A maximum likelihood tree was built using FastTree v2.1.10
Double precision using parameters (–gamma –spr 4 –mlacc 2)
(Price et al., 2010), with the tree rooted on M. abscessus
ATCC 19977 using Archaeopteryx 0.99212 (Zmasek, 2015).
Searches were performed using http://www.pathogenomics.sfu.
ca/islandviewer/, http://phast.wishartlab.com/, https://cge.cbs.
dtu.dk/services/PathogenFinder/ (Cosentino et al., 2013) and the
virulence factor database (VFDB) (Chen et al., 2016). Prediction
of gene clusters involved in antibiotic and secondary metabolite
production used antiSMASH v4.0.03 (Weber et al., 2015).
1http://ggdc.dsmz.de/ggdc.php#
2https://sites.google.com/site/cmzmasek/home/software/archaeopteryx
3https://antismash.secondarymetabolites.org/
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Accession Numbers
Read data generated for this study, and the annotated assembly of
the type strain 901379, can be found in the European Nucleotide
Archive (ENA4) under project number PRJEB23647, accession
number LR130759.
RESULTS
Clinical Cases of New Mycobacterial
Species
An undescribed Mycobacterium species was first cultured from
bronchoalveolar lavage (BAL) samples from patient 1 in 2013.
The same Mycobacterium sp. was cultured and isolated from BAL
and bronchial secretion specimens from four further patients,
attending three healthcare providers, in 2016 and 2017. Four of
the five patients had underlying lung conditions. A summary of
the five case histories is given in Table 1, with detailed case reports
in Supplementary File 2. Case reports were made as thoroughly
as possible, yet no clear common source of infection (geographic
or healthcare provider) could be identified. In four of the cases,
infection was associated with cough, hemoptysis and/or dyspnea.
Yet only one case fulfilled ATS (American Thoracic Society)
guideline criteria, indicative of non-mycobacterial pulmonary
disease (Griffith et al., 2007). Treatment was not administered
in most cases, yet subsequent samples were culture negative in
three cases (of four in which further samples were tested). All
six isolates of Mycobacterium were diagnosed by the molecular
genotyping test (Hain), however, test band patterns indicated an
inconclusive result (Genotype 1.2.3.9.10.13.15, the latter variably
present) (Lee et al., 2009).
Identification by 16S rRNA Gene
Sequencing
Species identification was attempted by sequencing a 16S rRNA
gene fragment covering the hypervariable regions A and B, which
are used for mycobacterial species identification (Boddinghaus
et al., 1990). The six isolates possess identical 16S rRNA gene
4http://www.ebi.ac.uk/ena/
sequences, with top Blastn hits (nr/nt and 16S rRNA databases)
to M. marinum (AB716939; 767/771, 99.5%) and M. ulcerans
(AB548729; 767/771, 99.5%), as these latter species have identical
sequences over this region.
Phenotypic Characterization of Novel
Strain
Bacteria were cultivated from six respiratory samples from
five patients. Ziehl-Neelsen and auramine-rhodamine staining
showed acid-fast, 3.2 ± 0.6 µm long, rod-shaped bacilli.
Cords, spores or filaments were not observed. Growth of strain
901379 on Middlebrook 7H10 agar plates at 30◦C showed non-
photochromogenic, white, slightly undulated colonies, apparent
after approximately 10 days of incubation, making this a slow
growing Mycobacterium (Brown-Elliott and Wallace, 2002).
The biochemical characteristics of strain 901379 were similar
to those of M. marinum and M. ulcerans (Table 2). The
most striking exception is its ability to grow at 37◦C. AST
revealed full susceptibility of this strain to all antibiotics tested
(Table 3). Furthermore, phenotypic detection of pyrazinamidase
(Table 2) indicates that the strain is sensitive to pyrazinamide.
Analysis of the cell wall mycolic acids by HPLC demonstrated
a unique profile for strain 901379, clearly distinct from those of
M. marinum and M. tuberculosis (Figure 1).
MALDI-TOF MS routine identification did not produce a
clear result (“No Identification Possible”). A consensus mass peak
profile of all M. basiliense isolates was generated and compared
to peak profiles of M. marinum; no M. basiliense-specific peaks
were identified. A representative mass spectrum of M. basiliense
is given in Supplementary Figure S1.
Intracellular Growth in Macrophages and
Amoebae
Isolate 901379 was able to grow in phagocytic THP-1
macrophages when infected at an MOI of 10, as documented
by PCR and by counting CFUs (Figures 2A,B). Ziehl–Neelsen
staining showed an increased ratio of infected THP-1 cells over
the time course of the infection (Figure 3A). However, at MOI 5
in THP-1 cells, growth was limited.
TABLE 2 | Biochemical and growth characteristics of M. basiliense.
Characteristics M.basiliense M. marinum∗ M. ulcerans∗ M. tuberculosis∗
Growth at 30◦C + + + +
Growth at 37◦C + − − +
Photochromogenicity N P N N
Nitrate reduction − − − +
Pyrazinamidase∗∗ + + − +
Urease + + V ±
Tellurite reduction + −/+ − −/+
TWEEN 80 hydrolysis − − − ±
Growth on MacConkey agar − − − −
+, positive; −, negative; ±, usually present; −/+, usually absent; V, variable; P, photochromogenic; N, non-chromogenic; ND, not determined. ∗Data for M. marinum, M.
ulcerans, and M. tuberculosis were retrieved from literature (Murray et al., 2007). ∗∗ Identified in the genome as MB901379_02799.
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TABLE 3 | Antimicrobial susceptibility testing.
Antibiotic Concentration
range tested
(mg/l)
MIC (mg/l) for
analyzed isolates
Interpretation
Clarithromycin 4–64 ≤4–16 S
Rifampicin 1–20 ≤1–4 S
Rifabutin 0.1–2 ≤0.1–0.4 S
Ethambutol 5–50 <5 S
Amikacin 1–20 ≤1–4 S
Moxifloxacin 0.5–10 ≤0.5 S
Clofazimine 1–2 ≤1 S
Linezolid 1–16 ≤1–4 S
Isolates were tested in MGIT 960 supplemented with the indicated antibiotics.
Strain 901379 was susceptible to the lowest concentration tested of all antibiotics.
No growth was detected in the amoebae A. castellanii when
infected at MOI 10 or 5 by qPCR, CFU counting or microscopy.
Ziehl–Neelsen staining also showed a reduced percentage of
infected cells over time (Figure 3B), indicating that mycobacteria
did not survive internalization.
A Novel Species of Mycobacterium
Defined by Genomics
A single scaffold of 5.6 Mb was obtained through hybrid
assembly of PacBio and Illumina sequencing data, representing
the chromosome of strain 901379. A phylogenetic tree comparing
the core genome of strain 901379 to that of other slow
growing mycobacteria (Figure 4) shows that it is divergent
from other species, and positioned most closely to M. ulcerans
and M. marinum. Comparison of the genome assembly
with those from closely related mycobacterial species was
performed using average nucleotide identity (ANI) and digital
DNA:DNA hybridization (dDDH) (Table 4), with both methods
indicating that strain 901379 represents a new species of
Mycobacterium. We have named this species M. basiliense sp.
nov., as all the patients were diagnosed in the Basel area of
Switzerland.
Genome Overview
The annotated genome draft of M. basiliense comprises
5,607,630 bp, containing 4,817 predicted coding sequences
(CDSs) (Figure 5 and Table 5). This is on a par with the size of
the M. ulcerans genome (Stinear et al., 2007), 1 Mb smaller than
that of the “more ancestral” M. marinum (Stinear et al., 2008)
and 1.2 Mb larger than that of M. tuberculosis (Cole et al., 1998).
No evidence of a plasmid was found, with over 99% of MiSeq
reads mapping to the assembled chromosome. Through curation
of PHAST and Island Viewer results, the presence of four phages
was predicted, carrying cargoes of genes encoding hypothetical
proteins and a restriction modification system (Supplementary
Table S1), indicating that M. basiliense has the capacity for
lateral gene transfer. The single ribosomal RNA operon is located
1.5 Mb distant from the origin of replication, which is thought
to be associated with slow growth in M. tuberculosis (Cole et al.,
1998).
FIGURE 1 | Representative high-performance liquid chromatography (HPLC)
patterns showing cell-wall mycolic acid content of Mycobacterium basiliense
in comparison with M. marinum and M. tuberculosis. Numbers indicate
retention times (minutes). ITS, internal standard.
A comparison against the genomes of M. marinum and
M. ulcerans shows that the genome of M. basiliense has retained
synteny with M. marinum (Figure 6). Four large insertions
are apparent, three of which encode for T1pks systems (see
below), and the fourth contains an array of genes encoding
PE/PPE proteins, named after conserved N terminal proline-
glutamate (PE) or proline-proline-glutamate (PPE) motifs.
Regions of the M. marinum genome which are absent from
M. basiliense comprise up to 1Mb of sequence and include: three
polyketide synthase clusters; five non-ribosomal peptide synthase
clusters; seven putative phages; several transposases; several genes
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FIGURE 2 | Growth in THP-1 human macrophages and in Acanthamoeba
castellanii ATCC 30010. (A) DNA copies/ml over the growth time (means ± 2
standard deviations). (B) CFU/ml over the growth time (means ± 2 standard
deviations).
encoding virulence proteins within the families PE, PPE and
mce (mammalian cell entry); and various dehydrogenase, mono-
oxygenase and P450 encoding genes, which may be involved
in metabolite hydroxylation or oxidation of xenobiotics (Stinear
et al., 2008).
Through manual curation of the M. basiliense genome
annotation, in comparison to that of M. marinum strain M, 19
putative pseudogenes were identified (Supplementary Table S2).
This is fewer than the 65 annotated in M. marinum (Stinear et al.,
2008), whereas M. ulcerans possesses 771 (Stinear et al., 2007). In
a similar vein, M. basiliense possesses only seven CDSs annotated
as transposases, representing possibly five insertion sequences
(IS), and with no signs of IS expansion, whereas the genomes
of M. ulcerans and M. tuberculosis contain expanded IS families,
which can also have a gene-disruptive effect. This all indicates
that M. basiliense, along with M. marinum, represents a more
ancestral genomic organization and content than M. ulcerans and
M. tuberculosis.
Pathogenic Potential and Virulence
Genes encoding common virulence associated proteins within
the mycobacteria are also found within the genomes of strain
901379. The vast majority of mycobacterial virulence factors,
as defined within the virulence factor database (Chen et al.,
2016), were identified within the genome of strain 901379
(Supplementary Table S3), and M. basiliense was predicted to be
a human pathogen by PathogenFinder, with a probability of 0.89
(Cosentino et al., 2013).
The PE/PPE family comprise specific mycobacterial virulence
factors, thought to be involved with antigenic variation and
immunopathogenicity (Cole et al., 1998; Stinear et al., 2008).
FIGURE 3 | THP-1 macrophage infection shown using Ziehl-Neelsen staining.
(A) THP-1 cells strained with ZN 24 and 96 h post-infection with an MOI of
10. Mycobacteria were observed in the extracellular medium, probably
explained by recent host cell lysis events; extracellular growth is unlikely to
have occurred because infected cells were treated with gentamycin to remove
bacteria that were not internalized. (B) Ratio of the infected cells to the total
number of cells counted (means ± 2 standard deviations). The asterisks (∗)
indicate the timepoints at which each condition was significantly different from
another by doing pair-wise chi-squared tests between pairs of triplicates with
five degrees of freedom (p-value < 0.05).
The genome of strain 901379 contains 202 and 81 CDS
members of PE/PPE families, respectively, representing 10%
of the coding potential of the genome, on a par with the
genome of M. marinum, and possibly indicative of a diverse host
range. These proteins are exported through the ESX/Type VII
secretion system (Simeone et al., 2015), of which components
are found in several gene clusters throughout the genome.
Another family of virulence proteins, well represented within
the genome of strain 901379 is that of mce, associated with the
invasion process and prolonged existence in host macrophages
(Zhang and Xie, 2011). There are 30 genes encoding members
of this family, organized within five clusters, similar to the
29 found within M. marinum. In addition, three haemolysins
have been predicted: MB901379_02511, 02512, 03838, along with
many other genes involved in antigen and immunogenic protein
production.
Polyketide synthesis operons and others involved in
non-ribosomal peptide synthesis (NRPS) are known to be
common in the genomes of mycobacteria, responsible for
the production of cell wall-associated lipids, siderophores
and other biologically active molecules (Cole et al., 1998;
Stinear et al., 2008). A list of 22 such gene clusters identified
within M. basiliense is given in Supplementary Table S4. The
presence of over 200 predicted regulators shows the versatility
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FIGURE 4 | Core genome phylogeny of slow growing mycobacterial species. M. basiliense can be seen to be most closely related to M. ulcerans, M. marinum, M.
ulcerans ecovar liflandii and M. pseudoshottsii, as well as to the M. kansasii complex. Shared core genes (n = 768) were obtained through clustering CDSs into
orthologous groups using OrthoFinder v2.2.1 (Emms and Kelly, 2015). Single-copy orthologous genes were aligned using Mafft v7.310 (Katoh and Standley, 2013),
resulting in a concatenated alignment of 283,167 amino acids. A maximum likelihood tree was built using FastTree v2.1.10 Double precision using parameters
(–gamma –spr 4 –mlacc 2) (Price et al., 2010). The tree was rooted on M. abscessus ATCC 19977 using Archaeopteryx 0.9921 (Zmasek, 2015)
(https://sites.google.com/site/cmzmasek/home/software/archaeopteryx). The scale bar represents the number of amino acids substitutions per site alongside the
branches. Nodes supports are based on the Shimodaira-Hasegawa (SH) test. NB, BLAST (using BLASTn) of the M. shottsii-specific F5 fragment (accession number
HM149249) against the M. basiliense assembly returned no hit.
TABLE 4 | Comparison of the genome of strain 901379 other mycobacterial genomes.
Reference genome, Accession ANI (%), two way dDDH Prob. DDH ≥ 70% %G+C difference
M. ulcerans ecovar liflandii 128FXT CP003899 81.15 23.3 0 0.59
M. marinum M CP000854 81.14 23.2 0 0.7
M. pseudoshottsii JCM 15466 AP018410 81.09 23.2 0 0.62
M. ulcerans Agy99 CP000325 81.00 23.2 0 0.45
M. tuberculosis H37Rv CP009480 79.99 22.3 0 0.58
New species are described with an ANI < 95% and dDDH < 70%. ANI was calculated at http://enve-omics.ce.gatech.edu/ani/ (Goris et al., 2007) and dDDH at
http://ggdc.dsmz.de/ggdc.php (Auch et al., 2010) using the results of formula 2.
of M. basiliense in gene expression, with 19 sigma factors and
over 30 serine/threonine protein kinases, comparable with
M. marinum.
Of genes identified as being putatively involved in drug
resistance, several did not have homologs in M. marinum,
in particular the MFS transporters (MB901379_00088, 01067,
02557, 03180, 03953), and the ABC transporter encoding operon
MB901379_00248-50. Although M. basiliense has low minimum
inhibitory concentrations (MIC) to all tested antibiotics, there
are CDSs predicted to encode six putative aminoglycoside
phosphotransferase, one aminoglycoside acetyltransferase, 11
putative drug eﬄux pumps, eight putative beta-lactamases, and
over 30 additional CDSs annotated as being involved in ABC
transport.
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FIGURE 5 | Circular map of the draft genome of M. basiliense strain 901379. The 5.6 Mb chromosome is represented as a circle, with ticks every 1 Mb. The circles
represent, from outside to inside: CDSs encoded on the forward strand; CDSs encoded on the reverse strand; tRNAs (blue) and rRNAs (green); pseudogenes
(brown); CDSs encoding PE (red), PPE (pink) and Mce (orange) proteins; regions not present in M. marinum strain M (green); G+C content; G+C skew. Figure was
produced in DNAPlotter (Carver et al., 2009).
Variation Between Clinical Isolates of
M. basiliense
All six isolates of M. basiliense, from five patients, were subjected
to whole genome sequencing. Variants were identified between
these genomes using variant calling followed by careful manual
checking. The isolates were found to vary by a maximum
of two SNPs from the type strain (Figure 7), after excluding
SNPs within repetitive NRPS genes, which were attributed to
imperfect mapping. These SNPs are located in MB901379_01152
(synonymous) and the regulator MB901379_01152, causing
A174G, in isolates 902333-16 and 903442-16. Isolate 902167-
17 has two non-synonymous SNPs, causing V555G in putative
ribonuclease MB901379_01783, and elimination of the STOP
codon of the PPE family member MB901379_02461, extending
the C terminus by 62 residues. This isolate also possesses a 3 bp
duplication at the 3′ end of MB901379_03561, encoding ATP
synthase I chain. Other than this, no further genomic differences
between the six isolates could reliably be called. The two isolates
from the same patient, separated by a 9-month period between
sampling, are identical.
TABLE 5 | Genome features of M. basiliense strain 901379.
Draft genome size 5607630 bp
% G+C content 65
Predicted CDSs 4817
Coding density 0.86
Average gene length 1048
Pseudogenes 19
rRNA operons 1
tRNAs 53
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FIGURE 6 | Comparison of the genomes of M. basiliense 901379 (middle) with M. marinum M (CP000854, top) and M. ulcerans Agy99 (CP000325, bottom).
Genomes are depicted linearly with predicted CDSs as blue vertical lines. Blastn hits between the genomes (identity shown in scale) show that the genome of
M. basiliense is syntenic with that of M. marinum, whereas the genome of M. ulcerans contains many rearrangements. Figure was drawn using Easyfig (Sullivan
et al., 2011).
FIGURE 7 | Genome phylogeny of six M. basiliense isolates. SNP phylogeny
of the full genome based on high quality, manually checked SNPs. Root is
assigned to the type strain (earliest isolate, bold), which was also the mapping
reference. Additional isolates, identified by isolate number and patient, vary by
a maximum of two SNPs from the root.
Few estimates exist for mutation rates of mycobacterial
species, with that of M. tuberculosis estimated at 0.3–0.5
mutations per genome per year over a 10-year period (Ford
et al., 2011, 2013), and no temporal signal identified in a study
of M. ulcerans (Doig et al., 2012). The M. basiliense isolates show
0–2 SNPs occurring over 3–4 years, which would fit with the
above estimate, assuming a possibly common source of infection,
although there is no epidemiological evidence for this. This
low rate may be associated with a slow replication rate and an
unknown environmental reservoir.
Taxonomic Description of
Mycobacterium basiliense sp. nov
A slow growing, acid-fast, rod-shaped bacillus (901379) was
isolated from human bronchoalveolar lavage. On the basis
of 16S rRNA gene sequence similarity, strain 901379 was
shown to belong to mycobacterial genus of actinobacteria, most
closely related to both M. marinum (99.7%) and M. ulcerans
(99.5%). Physiological and biochemical characterization revealed
the following traits for the isolate: growth at 37◦C, no
photochromogenicity, nitrate reduction negative, pyrazinamide
positive, urease positive, tellurite reduction positive, TWEEN 80
hydrolysis negative, no growth on MacConkey agar (Table 1).
HPLC analysis of cell-wall mycolic acids revealed a pattern
clearly distinct from its close relative M. marinum. The results
of digital DNA–DNA hybridization and ANI allowed genotypic
differentiation of strain 901379 from the validly published
mycobacterial species. Strain 901379 therefore represents a new
species, for which the name M. basiliense sp. nov. (ba.si.li’en.se.
N.L. neut. adj. basiliensis pertaining to the city of Basel,
Switzerland) is proposed, with the type strain 901379 (=DSM
104308 = CCOS1136 = CIP 111488T).
DISCUSSION
We describe a new species of slow growing Mycobacterium, which
we have named M. basiliense. The genome of M. basiliense is rich
in virulence factors, as well as being highly intact, resembling
in structure more that of M. marinum, than M. ulcerans or
M. tuberculosis, and possibly representing a genome of a common
ancestor. The latter two species are highly specialized for specific
pathogenic niches, illustrated by genomes which have undergone
reduction and which, in the case of M. ulcerans, is replete with IS
elements and pseudogenes, and has gained a virulence plasmid.
From this we can predict that M. basiliense is a generalist, capable of
environmental/extracellular survival, but is potentially pathogenic
with likely intracellular persistence and a possibly diverse host
range.
Although the genomic findings are suggestive of a pathogen,
the clinical description indicates that the infection is not severe,
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and may just represent colonization. M. basiliense was isolated
from human respiratory samples, yet the clinical significance
is unclear as the bacterium appeared to clear in several cases
without treatment. Associated symptoms may include cough,
even hemoptysis, and shortness of breath, although these were
observed in patients with underlying lung disease. Interesting
phenotypic features of M. basiliense include the ability to grow
at 37◦C; sensitivity to all tested antibiotics could indicate a lack of
previous exposure of these isolates to such drugs.
The ability to grow in human macrophages is indicative of
pathogenic behavior, as is the inability to grow in A. castellanii
(Greub and Raoult, 2004). This latter finding also suggests that
the reservoir of these bacteria is not aqueous, in contrast to many
other NTM such as M. avium (Danelishvili et al., 2007) and
M. kansasii (Goy et al., 2007), although a wide diversity of amoeba
can be encountered in aqueous environments, and we tested only
one species.
It is interesting that M. basiliense has not previously
been identified and characterized, and that all isolates of
this species to date were found in the area around Basel,
Switzerland. The genotype (Hain) of this species is unique,
as is the 16S rRNA gene sequence, and we anticipate
that this species will be found more widely with this new
data and interpretation. The patients were treated at three
healthcare centers, which would appear to rule out the
possibility of these isolates having arisen somehow as a
contaminant.
The transmission and source of these cases is unknown;
that the isolates we have studied are so closely related
may indicate a common source of infection for these
cases, which we could not identify from case reports. In
the case of M. basiliense, the genome content suggests a
higher virulence potential than is seen in the self-limited
infections described, meaning that the potential of this as
an emerging pathogen is also unknown. This novel species
opens up more possibilities for investigations in mycobacteria,
and may represent a useful model for future mycobacterial
studies.
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